Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-22

Clinical Trial Update: Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating antioxidant supplementation to prevent Acute Mountain Sickness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antioxidant supplementation (unspecified) (unspecified antioxidant)

Snippet

Sponsor: Altitude Physiology Expeditions | Conditions: Acute Mountain Sickness | Phase 3 | Status: COMPLETED